• 2025
  • 07 기술성평가 통과
• 2024
  • 07 NXC736 Pluto사 기술이전(신규 적응증)
  • 06 NXC680 임상1상 IND 승인
  • 04 NXC736 국가신약개발사업단(KDDF) 임상2상 과제 선정
• 2023
  • 10 NXC736 임상2상 IND 승인
  • 07 스케일업팁스 R&D 과제 선정
  • 01 NXC680 미국 식품의약국 희귀의약품 지정
• 2022
  • 12 NXC736 임상 1상 완료
  • 12 Series B-ext 유상증자
  • 11 직무발명 우수기업 인증
• 2021
  • 12 SI 유상증자
  • 08 NXC736 국내 임상1상 IND 승인
  • 06 본사 이전(경기도 성남시 분당구 판교로 228번길 17)
  • 기업부설연구소(신약탐색연구소) 인증
• 2020
  • 07 Series B 유상증자(한국산업은행, 한국투자신탁운용, 한국투자파트너스, DSC인베스트먼트 유상증자)
  • 07 방사선 폐섬유화 치료제 임상 후보물질 도출 과제 선정(과학기술정보통신부)
  • 04 NXC736 첨단의료기술 개발 과제 선정(보건복지부)
• 2019
  • 11 기업부설연구소(신약공정연구소) 인증
  • 07 Series A 유상증자(한국투자파트너스, DSC인베스트먼트, 슈미트 유상증자)
  • 05 기업부설연구소(신약평가연구소) 인증
  • 01 벤처기업 인증
• 2018
  • 12 Pre A 유상증자(한국투자파트너스, DSC인베스트먼트, 슈미트 유상증자)
  • 11 판교 사무실 개소(경기도 성남시 분당구 대왕판교로 670)
  • 08 넥스트젠바이오사이언스 법인설립

• 2025
  • July Passed the KOSDAQ Listing Technology Assessment
• 2024
  • July Technology transfer of NXC736 to Pluto (New indication)
  • June IND approval for Phase 1 clinical trial of NXC680
  • April Government funding for NXC736 Phase 2 clinical trial by KDDF
• 2023
  • October IND approval for Phase 2 clinical trial of NXC736
  • July Government funding for Scale-up TIPS R&D program
  • January NXC680 designated as an orphan drug by the U.S. FDA
• 2022
  • December Completion of Phase 1 clinical trial for NXC736
  • December Series B-ext funding
  • November Certification as an Excellent Company for Employee Inventions
• 2021
  • December Strategic investment
  • August IND approval for Phase 1 clinical trial of NXC736 in Korea
  • June Office relocation Research Center certification(New Drug Discovery Center)
• 2020
  • July Series B funding
    Government funding for RIPF treatment R&D by Ministry of Science and ICT
  • April Government funding for advanced medical technology R&D by Ministry of Health and Welfare
• 2019
  • November Research Center certification(New Drug Process Development Center)
  • July Series A funding
  • May Research Center certification(New Drug Evaluation Center)
  • January Certificaton of Venture Enterprise
• 2018
  • December Pre-A funding
  • November Opened Pangyo Office
  • August Founded